Edition:
United States

Genesis Healthcare Inc (GEN)

GEN on New York Consolidated

1.39USD
16 Feb 2018
Change (% chg)

-- (--)
Prev Close
$1.39
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
495,050
52-wk High
$3.97
52-wk Low
$0.60

Latest Key Developments (Source: Significant Developments)

Genesis Healthcare To Extend "Lock-Up" Period Of Shares Until July 31
Friday, 16 Feb 2018 09:30am EST 

Feb 16 (Reuters) - Genesis Healthcare Inc ::GENESIS HEALTHCARE- ON FEB 15, HOLDERS OF MAJORITY OF VOTING POWER OF CO'S COMMON STOCK ENTERED INTO FOURTH AMENDED & RESTATED VOTING AGREEMENT.GENESIS HEALTHCARE SAYS PURSUANT TO AGREEMENT, MEMBERS OF VOTING GROUP TO EXTEND "LOCK-UP" PERIOD OF SHARES OF CO'S COMMON STOCK UNTIL JULY 31, 2018.  Full Article

Genesis Healthcare reports Q3 revenue $1.32 billion
Wednesday, 8 Nov 2017 04:20pm EST 

Nov 8 (Reuters) - Genesis Healthcare Inc ::Genesis Healthcare announces plans to strengthen capital structure and reports third quarter 2017 results.Q3 revenue $1.32 billion versus i/b/e/s view $1.33 billion.Genesis Healthcare Inc - co, counterparties entered preliminary non-binding agreements for proposed restructuring of master leases, loans​.Genesis Healthcare - ‍restructuring plans expected to reduce current cash fixed charges between $80 million and $100 million annually​.Genesis Healthcare - ‍non-cash impairment charge of $360 million for goodwill and identifiable intangible assets recorded in quarter.Genesis Healthcare Inc qtrly earnings per share ‍loss from continuing operations attributable to co $3.94​.  Full Article

Blue Earth Diagnostics, GE Healthcare sign UK manufacturing deal
Monday, 2 Oct 2017 04:00am EDT 

Oct 2 (Reuters) - ‍BLUE EARTH DIAGNOSTICS::‍BLUE EARTH DIAGNOSTICS AND GE HEALTHCARE SIGN UK MANUFACTURING AGREEMENT​.‍AGREEMENT MARKS FIRST STEP TOWARDS FULL COMMERCIAL AVAILABILITY OF AXUMIN® (FLUCICLOVINE ((18)F)) IN UK​.  Full Article

Genesis HealthCare reports q2 net loss attributable of $0.70
Tuesday, 8 Aug 2017 08:59pm EDT 

Aug 9 (Reuters) - Genesis HealthCare Inc -:Genesis HealthCare reports second quarter 2017 results.Q2 revenue $1.34 billion versus I/B/E/S view $1.34 billion.Qtrly net loss attributable is $0.70.  Full Article

Genesis Healthcare to pay $53.6 mln to settle federal lawsuits, probes -statement
Friday, 16 Jun 2017 11:11am EDT 

June 16 (Reuters) - Genesis Healthcare :To pay the federal government $53.6 million to settle six federal lawsuits and investigations alleging that companies it acquired violated false claims act -Justice Department statement.Claims resolved by genesis settlement are allegations only, has been no determination of liability, Justice Department says.  Full Article

Genesis Healthcare says Qtrly loss from continuing operations $0.55 per common share
Tuesday, 9 May 2017 06:00am EDT 

May 9 (Reuters) - Genesis Healthcare Inc :Genesis Healthcare reports first quarter 2017 results.Reaffirming previously announced guidance ranges for 2017, except for revenue and net loss attributable to co .Q1 revenue $1.39 billion versus i/b/e/s view $1.37 billion.Qtrly loss from continuing operations attributable to Genesis Healthcare $ 0.55 per common share.Sees 2017 gaap revenue $5,400.0 million to $5,500.0 million.Expects to divest an additional 12 underperforming assets or assets in non-strategic markets during remainder of 2017.FY2017 revenue view $5.47 billion -- Thomson Reuters I/B/E/S.Sees 2017 net loss attributable to genesis healthcare, inc. $ 159.0 million to $148.0 million.  Full Article

Genesis Healthcare says Steven Fishman to resign from board effective immediately
Friday, 7 Apr 2017 05:37pm EDT 

Genesis Healthcare Inc : Genesis Healthcare Inc - on April 7, Steven Fishman notified company's board of directors of his decision to resign from board effective immediately .On April 7, 2017, board appointed Robert Fish, a current board member, as chairman of board.  Full Article

Genesis Healthcare reports Q4 revenue $1.4 bln
Wednesday, 22 Feb 2017 06:21pm EST 

Genesis Healthcare Inc : Genesis Healthcare reports fourth quarter and fiscal year end 2016 results . Q4 revenue $1.4 billion versus I/B/E/S view $1.4 billion . In 2017, genesis expects to divest 31 underperforming assets or assets in non-strategic markets . U.S. GAAP net income attributable To Genesis Healthcare in Q4 of 2016 was $22.5 million . Sees 2017 revenue $5,400.0 million to $5,600.0 million . Sees $50 million of overhead and net operating cost reductions in 2017 . Sees 2017 net loss attributed to GHC of $85.0 million to $74.0 million .FY2017 revenue view $5.64 billion -- Thomson Reuters I/B/E/S.  Full Article

Genesis Healthcare reports qtrly loss per share $0.23
Thursday, 3 Nov 2016 04:01pm EDT 

Genesis Healthcare Inc : Genesis healthcare reports third quarter 2016 results . US gaap net loss attributable to genesis healthcare in q3 of 2016 was $20.5 million versus gaap net loss of $29.0 million in q3 of 2015 . Genesis healthcare inc qtrly loss per share $0.23 . Genesis healthcare reports third quarter 2016 results .Q3 revenue $1.419 billion versus i/b/e/s view $1.39 billion.  Full Article

Genesis Healthcare reports Q2 cont ops loss per share $0.26
Thursday, 4 Aug 2016 04:35pm EDT 

Genesis Healthcare Inc : Genesis healthcare reports second quarter 2016 results . Qtrly revenue $1.44 billion versus $ 1.42 billion . Q2 earnings per share view $0.01, revenue view $1.40 billion -- Thomson Reuters I/B/E/S . Says reaffirms its previously announced guidance for fiscal 2016. .Qtrly loss per share $0.26 from continuing operations.  Full Article

BRIEF-Genesis Healthcare To Extend "Lock-Up" Period Of Shares Until July 31

* GENESIS HEALTHCARE- ON FEB 15, HOLDERS OF MAJORITY OF VOTING POWER OF CO'S COMMON STOCK ENTERED INTO FOURTH AMENDED & RESTATED VOTING AGREEMENT